Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (73) 73
humans (67) 67
female (48) 48
male (47) 47
alaska - epidemiology (43) 43
adult (42) 42
infectious diseases (37) 37
middle aged (36) 36
child, preschool (34) 34
infant (30) 30
immunology (29) 29
adolescent (28) 28
alaska (27) 27
child (26) 26
united-states (25) 25
aged (24) 24
children (24) 24
microbiology (22) 22
epidemiology (19) 19
infant, newborn (19) 19
infections (19) 19
risk factors (19) 19
abridged index medicus (16) 16
public, environmental & occupational health (15) 15
young adult (15) 15
aged, 80 and over (14) 14
pneumococcal infections - epidemiology (14) 14
alaska natives (13) 13
disease (13) 13
population (13) 13
research (13) 13
antimicrobial resistance (12) 12
gastroenterology & hepatology (12) 12
surveillance (12) 12
time factors (12) 12
carrier state - epidemiology (11) 11
infection (11) 11
prevalence (11) 11
risk-factors (11) 11
streptococcus pneumoniae (11) 11
alaska native (10) 10
cohort studies (10) 10
conjugate vaccine (10) 10
incidence (10) 10
pediatrics (10) 10
pneumococcal vaccines - administration & dosage (10) 10
retrospective studies (10) 10
carrier state - microbiology (9) 9
genotype (9) 9
health aspects (9) 9
hepatitis c (9) 9
impact (9) 9
pneumococcal infections - prevention & control (9) 9
vaccines (9) 9
virus-infection (9) 9
article (8) 8
bacteria (8) 8
hepacivirus - genetics (8) 8
hepatitis (8) 8
indians, north american (8) 8
infants (8) 8
rural population (8) 8
streptococcus pneumoniae - classification (8) 8
streptococcus pneumoniae - isolation & purification (8) 8
analysis (7) 7
biopsy (7) 7
follow-up studies (7) 7
helicobacter pylori (7) 7
heptavalent pneumococcal conjugate vaccine (7) 7
hospitalization - statistics & numerical data (7) 7
invasive pneumococcal disease (7) 7
microbial sensitivity tests (7) 7
nasopharynx - microbiology (7) 7
respiratory syncytial virus (7) 7
serotyping (7) 7
strains (7) 7
streptococcus pneumoniae - drug effects (7) 7
anti-bacterial agents - pharmacology (6) 6
antibodies (6) 6
bacterial infections and mycoses (6) 6
carriage (6) 6
colonization (6) 6
disease outbreaks (6) 6
drug resistance, bacterial (6) 6
efficacy (6) 6
helicobacter infections - epidemiology (6) 6
helicobacter pylori - isolation & purification (6) 6
immunization (6) 6
immunogenicity (6) 6
pneumococcal infections - microbiology (6) 6
pneumococcal vaccines - immunology (6) 6
prospective studies (6) 6
risk assessment (6) 6
streptococcus-pneumoniae (6) 6
vaccination (6) 6
age (5) 5
age factors (5) 5
anti-bacterial agents - therapeutic use (5) 5
antibiotics (5) 5
arctic medicine. tropical medicine (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by streptococcus pneumoniae - Alaska, 2008-2012
by Gounder, Prabhu P and Bruce, Michael G and Bruden, Dana J. T and Singleton, Rosalyn J and Rudolph, Karen and Hurlburt, Debby A and Hennessy, Thomas W and Wenger, Jay
Journal of Infectious Diseases, ISSN 0022-1899, 04/2014, Volume 209, Issue 8, pp. 1251 - 1258
Background. In 2010, a 13-valent pneumococcal conjugate vaccine (PCV13) replaced a 7-valent vaccine (PCV7) that contained all PCV7 serotypes plus 6 additional... 
Alaska | conjugate vaccine | Alaska Native people | nasopharyngeal colonization | Streptococcus pneumoniae | INFECTIOUS DISEASES | CARRIAGE | INVASIVE DISEASE | MICROBIOLOGY | IMMUNOLOGY | ANTIMICROBIAL RESISTANCE | TRENDS | CHILDREN | SEROTYPES | IMPACT | ERA | EPIDEMIOLOGY | Prevalence | Nasopharyngeal Diseases - prevention & control | Humans | Vaccination | Child, Preschool | Male | Pneumococcal Vaccines - administration & dosage | Urban Population | Nasopharyngeal Diseases - microbiology | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Alaska - epidemiology | Nasopharyngeal Diseases - epidemiology | Rural Population | Adolescent | Pneumococcal Infections - prevention & control | Female | Pneumococcal Infections - microbiology | Nasopharynx - microbiology | Child | Index Medicus | Abridged Index Medicus | Conjugate vaccine | Nasopharyngeal colonization
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Risk of end‐stage liver disease, hepatocellular carcinoma, and liver‐related death by fibrosis stage in the hepatitis C Alaska Cohort
by Bruden, Dana J.T and McMahon, Brian J and Townshend‐Bulson, Lisa and Gounder, Prabhu and Gove, Jim and Plotnik, Julia and Homan, Chriss and Hewitt, Annette and Barbour, Youssef and Spradling, Philip R and Simons, Brenna C and McArdle, Susan and Bruce, Michael
Hepatology, ISSN 0270-9139, 07/2017, Volume 66, Issue 1, pp. 37 - 45
Long‐term prospective studies of the outcomes associated with hepatitis C virus (HCV) infection are rare and critical for assessing the potential impact of HCV... 
UNITED-STATES | MORTALITY | VIRUS-INFECTION | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | NATIVES | End Stage Liver Disease - therapy | Immunohistochemistry | Carcinoma, Hepatocellular - epidemiology | Confidence Intervals | Humans | Middle Aged | End Stage Liver Disease - epidemiology | Hepatitis C, Chronic - therapy | Male | Liver Neoplasms - therapy | Cause of Death | Liver Cirrhosis - epidemiology | Young Adult | Liver Neoplasms - epidemiology | Alaska - epidemiology | Liver Neoplasms - physiopathology | Adult | Female | Retrospective Studies | Hepatitis C, Chronic - epidemiology | Databases, Factual | Carcinoma, Hepatocellular - physiopathology | Comorbidity | Proportional Hazards Models | End Stage Liver Disease - physiopathology | Hepatitis C, Chronic - diagnosis | Disease Progression | Survival Analysis | Liver Cirrhosis - pathology | Aged | Carcinoma, Hepatocellular - therapy | Biopsy, Needle | Liver Cirrhosis - physiopathology | Cohort Studies | Cirrhosis | Liver cancer | Hepatitis | Liver diseases | Developmental stages | Biopsy | Fibrosis | Hepatocellular carcinoma | Hepatitis C | Index Medicus | Prospective Cohort | Liver Biopsy | HCV Treatment | Outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae, Alaska, 2000[FIGURE DASH]2010
by Gounder, Prabhu P and Brewster, Melissa and Bruce, Michael G and Bruden, Dana J T and Rudolph, Karen and Hurlburt, Debby A and Hennessy, Thomas W
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 11/2015, Volume 34, Issue 11, pp. 1223 - 1229
BACKGROUND:We describe the relative impact of the heptavalent pneumococcal conjugate vaccine (PCV7, introduced 2001) and antibiotic use on colonization by... 
Pneumococcal conjugate vaccine | Epidemiology | Streptococcus pneumonia | Antibiotic resistance | UNITED-STATES | INFECTIOUS DISEASES | CARRIAGE | IMMUNOLOGY | ANTIMICROBIAL RESISTANCE | CHILDREN | TRIAL | epidemiology | THERAPY | SECRETIONS | antibiotic resistance | ACUTE OTITIS-MEDIA | DISEASE | PEDIATRICS | pneumococcal conjugate vaccine | Carrier State - epidemiology | Streptococcus pneumoniae - drug effects | Cross-Sectional Studies | Humans | Carrier State - microbiology | Child, Preschool | Drug Resistance, Bacterial | Infant | Male | Pneumococcal Vaccines - administration & dosage | Vaccination - statistics & numerical data | Vaccines, Conjugate - administration & dosage | Pneumococcal Infections - epidemiology | Vaccines, Conjugate - immunology | Streptococcus pneumoniae - isolation & purification | Alaska - epidemiology | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Female | Pneumococcal Infections - microbiology | Nasopharynx - microbiology | Penicillins - pharmacology | Infant, Newborn | Index Medicus | Streptococcus pneumoniae
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Indirect Effect of Conjugate Vaccine on Adult Carriage of Streptococcus pneumoniae: An Explanation of Trends in Invasive Pneumococcal Disease
by Laura L. Hammitt and Dana L. Bruden and Jay C. Butler and Henry C. Baggett and Debby A. Hurlburt and Alisa Reasonover and Thomas W. Hennessy
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2006, Volume 193, Issue 11, pp. 1487 - 1494
Background. Use of heptavalent protein-polysaccharide pneumococcal conjugate vaccine (PCV7) has been associated with decreases in PCV7-type invasive... 
Pediatrics | Microbial colonization | Conjugate vaccines | Antimicrobials | Vaccination | Bacteria | Adults | Preventive medicine | Children | Age | Streptococcus pneumoniae | INFECTIOUS DISEASES | ACQUISITION | MICROBIOLOGY | COLONIZATION | IMMUNOLOGY | NASOPHARYNGEAL CARRIAGE | RURAL ALASKA | CHILDREN | IMMUNIZATION | TRANSMISSION | 1ST 2 YEARS | DAY-CARE-CENTERS | POLYSACCHARIDE VACCINE | Carrier State - epidemiology | Streptococcus pneumoniae - classification | Humans | Middle Aged | Carrier State - microbiology | Child, Preschool | Heptavalent Pneumococcal Conjugate Vaccine | Infant | Pneumococcal Vaccines - administration & dosage | Microbial Sensitivity Tests | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Penicillin Resistance | Adolescent | Pneumococcal Vaccines - immunology | Adult | Alaska | Pneumococcal Infections - microbiology | Meningococcal Vaccines - immunology | Nasopharynx - microbiology | Meningococcal Vaccines - administration & dosage | Serotyping | Care and treatment | Usage | Research | Vaccines | Health aspects | Pneumococcal infections | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Methicillin-Resistant Staphylococcus aureus —Associated Hospitalizations among the American Indian and Alaska Native Population
by Kathy K. Byrd and Robert C. Holman and Michael G. Bruce and Thomas W. Hennessy and Jay D. Wenger and Dana L. Bruden and Dana L. Haberling and Claudia Steiner and James E. Cheek
Clinical Infectious Diseases, ISSN 1058-4838, 10/2009, Volume 49, Issue 7, pp. 1009 - 1015
Background. American Indians and Alaska Natives (AI/ANs) have had documented outbreaks of methicillin-resistant Staphylococcus aureus (MRSA) infection but, to... 
Hospitalization rates | Health care costs | Infectious diseases | Alaska Natives | Hospitalization | Infections | Native Americans | IDSA PUBLIC POLICY | Epidemiology | Staphylococcus aureus | Age groups | UNITED-STATES | INFECTIOUS DISEASES | MICROBIOLOGY | INFECTIOUS-DISEASE HOSPITALIZATIONS | IMMUNOLOGY | BACTEREMIA | United States - epidemiology | Humans | Middle Aged | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Male | Incidence | Young Adult | Staphylococcal Infections - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Staphylococcal Infections - microbiology | Indians, North American | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Child | Infant, Newborn | Research | Demographic aspects | Hospital care | Staphylococcus aureus infections | Distribution | Tissue | Staphylococcus infections | Drug resistance | Comparative analysis | Medical diagnosis | Native North Americans | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
by Brian J. McMahon and Dana L. Bruden and Kenneth M. Petersen and Lisa R. Bulkow and Alan J. Parkinson and Omana Nainan and Marina Khristova and Carolyn Zanis and Helen Peters and Harold S. Margolis
Annals of Internal Medicine, ISSN 0003-4819, 03/2005, Volume 142, Issue 5, pp. 333 - 341
Background: The duration of protection afforded by hepatitis B vaccination is unknown. Objective: To determine antibody persistence and protection from... 
MEDICINE, GENERAL & INTERNAL | YUPIK ESKIMO POPULATION | HEALTH-CARE WORKERS | IMMUNOGENICITY | VIRUS-INFECTION | CHILDHOOD VACCINATION | INFANTS | SURFACE-ANTIGEN | ALASKA NATIVES | LONG-TERM EFFICACY | CHILDREN | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Vaccination | Child, Preschool | Hepatitis B Surface Antigens - immunology | Hepatitis B - epidemiology | Infant | Male | Antibodies, Viral - blood | DNA, Viral - blood | Alaska - epidemiology | Adolescent | Hepatitis B virus - genetics | Adult | Female | Hepatitis B Vaccines - immunology | Hepatitis B - prevention & control | Child | Hepatitis B virus - immunology | Viral antibodies | Antibodies | Hepatitis | Antigens | Infections | Vaccines | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C
by Livingston, Stephen E and Townshend-Bulson, Lisa J and Bruden, Dana J. T and Homan, Chriss E and Gove, James E and Plotnik, Julia N and Simons, Brenna C and Spradling, Philip R and McMahon, Brian J
International Journal of Circumpolar Health, ISSN 1239-9736, 01/2016, Volume 75, Issue 1, pp. 30696 - 8
There have been few reports of hepatitis C virus (HCV) treatment results with interferon-based regimens in indigenous populations. To determine... 
pegylated interferon | longitudinal study | indigenous population | sustained virologic response | discontinuation | Discontinuation | Pegylated interferon | Indigenous population | Sustained virologic response | Longitudinal study | PLUS RIBAVIRIN | VIRUS-INFECTION | TELAPREVIR | COMBINATION THERAPY | INITIAL TREATMENT | IMPACT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PEGINTERFERON ALPHA-2B | TRIPLE THERAPY | BOCEPREVIR | OUTCOMES | Hepacivirus - drug effects | Follow-Up Studies | Risk Assessment | Antiviral Agents - therapeutic use | Alaska Natives - statistics & numerical data | Humans | Middle Aged | Male | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Indians, North American - statistics & numerical data | Interferon-alpha - administration & dosage | Ribavirin - administration & dosage | Adult | Alaska | Female | Aged | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Longitudinal Studies | Substance abuse treatment | Liver diseases | Laboratories | Urban areas | Infections | Patients | Disease control | Consortia | Disease prevention | Genotype & phenotype | Hepatitis | Native peoples | Interferon | Liver cirrhosis | Multivariate analysis | Hepatology | Population | Native North Americans | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska
by Bruce, Michael G and Singleton, Rosalyn and Bulkow, Lisa and Rudolph, Karen and Zulz, Tammy and Gounder, Prabhu and Hurlburt, Debby and Bruden, Dana and Hennessy, Thomas
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 38, pp. 4813 - 4819
Abstract Background Alaska Native (AN) children have experienced high rates of invasive pneumococcal disease (IPD). In March 2010, PCV13 was introduced... 
Allergy and Immunology | Invasive pneumococcal disease | Alaska | Vaccine | Serotype | Streptococcus pneumoniae | Carriage | US | MEDICINE, RESEARCH & EXPERIMENTAL | NASOPHARYNGEAL COLONIZATION | IMMUNOLOGY | ANTIMICROBIAL RESISTANCE | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | SEROTYPE DISTRIBUTION | Carrier State - epidemiology | Streptococcus pneumoniae - classification | Humans | Middle Aged | Carrier State - microbiology | Child, Preschool | Infant | Male | Pneumococcal Vaccines - administration & dosage | Young Adult | Streptococcus pneumoniae - isolation & purification | Alaska - epidemiology | Aged, 80 and over | Adult | Female | Pneumococcal Infections - microbiology | Child | Infant, Newborn | Serogroup | Pneumococcal Infections - epidemiology | Carrier State - prevention & control | Adolescent | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Aged | Evaluation | Vaccines | Immunization | Pneumonia | Disease control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Observed Pneumococcal Carriage Among Alaska Native Children Who Received Reduced-Dose Schedules of 13-Valent Pneumococcal Conjugate Vaccine Between 2010 and 2012
by Mosites, E and Bruden, D and Bruce, MG and Hennessy, T and Gounder, P
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, pp. 1478 - 1479
INFECTIOUS DISEASES | MICROBIOLOGY | PCV13 | IMMUNOLOGY | DISEASE | Schedules | Children
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Hepatitis C in pregnant American Indian and Alaska Native women; 2003-2015
by Nolen, Leisha D and O'Malley, John C and Seeman, Sara S and Bruden, Dana J. T and Apostolou, Andria and McMahon, Brian J and Bruce, Michael G
International Journal of Circumpolar Health, ISSN 1239-9736, 01/2019, Volume 78, Issue 1, pp. 1608139 - 1608139
Recent reports have found a rise in Hepatitis C virus (HCV) infection in reproductive age women in the USA. Surveillance data suggests one group that is at... 
Hepatitis C | American Indian/Alaska Native | pregnancy | UNITED-STATES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | Alaska Native | VIRUS-INFECTION | RISK-FACTORS | DISEASE | HCV | VERTICAL TRANSMISSION | PREVALENCE | American Indian
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22-Year Follow-Up Study and Response to a Booster Dose
by Brian J. McMahon and Catherine M. Dentinger and Dana Bruden and Carolyn Zanis and Helen Peters and Debbie Hurlburt and Lisa Bulkow and Anthony E. Fiore and Beth P. Bell and Thomas W. Hennessy
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2009, Volume 200, Issue 9, pp. 1390 - 1396
Background. The duration of protection in children and adults (including health care workers) resulting from the hepatitis B vaccine primary series is unknown.... 
Hepatitis | Follow up studies | Surface antigens | Vaccination | Alaska Natives | Antibodies | Infections | Adults | Hepatitis B virus | Dosage | VIRUSES | IMMUNITY | INFECTIOUS DISEASES | YUPIK ESKIMO POPULATION | HEALTH-CARE WORKERS | VIRUS | EFFICACY | PERSISTENCE | GENOTYPE-F | MICROBIOLOGY | IMMUNOLOGY | CHILDREN | TRIAL | IMMUNOGENICITY | Follow-Up Studies | Humans | Middle Aged | Child, Preschool | Infant | Male | Young Adult | Hepatitis B Antibodies - blood | Immunization, Secondary | Adolescent | Adult | Female | Aged | Hepatitis B Vaccines - immunology | Hepatitis B Antibodies - immunology | Child | Viral antibodies | Physiological aspects | Hepatitis B vaccine | Dosage and administration | Research | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The Relationship Between In-Home Water Service and the Risk of Respiratory Tract, Skin, and Gastrointestinal Tract Infections Among Rural Alaska Natives
by Hennessy, Thomas W and Ritter, Troy and Holman, Robert C and Bruden, Dana L and Yorita, Krista L and Bulkow, Lisa and Cheek, James E and Singleton, Rosalyn J and Smith, Jeff
American Journal of Public Health, ISSN 0090-0036, 11/2008, Volume 98, Issue 11, pp. 2072 - 2078
Objectives. We investigated the relationship between the presence of in-home piped water and wastewater services and hospitalization rates for respiratory... 
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HOSPITALIZATIONS | TRENDS | CHILDREN | Respiratory Syncytial Virus Infections - epidemiology | Influenza, Human - ethnology | Gastrointestinal Diseases - epidemiology | Health Status Disparities | Respiratory Syncytial Virus Infections - ethnology | Humans | Middle Aged | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Skin Diseases, Infectious - epidemiology | Gastrointestinal Diseases - microbiology | Pneumonia - ethnology | Indians, North American - statistics & numerical data | Rural Health - statistics & numerical data | Alaska - epidemiology | Inuits - statistics & numerical data | Adult | Housing - classification | Child | Gastrointestinal Diseases - ethnology | Risk Assessment | Pneumonia - epidemiology | Influenza, Human - epidemiology | Skin Diseases, Infectious - ethnology | Adolescent | Respiratory Tract Infections - ethnology | Aged | Water Supply | Respiratory Tract Infections - epidemiology | Rural development | Hospitals | Native peoples | Infectious diseases | Disease | Health services | Sanitation services | Respiratory diseases | Staphylococcus infections | Discharge | Index Medicus | Abridged Index Medicus | Research and Practice
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Diagnostic accuracy of tests forHelicobacter pyloriin an Alaska Native population
by Bruden, Dana L
World Journal of Gastroenterology, ISSN 1007-9327, 2011, Volume 17, Issue 42, p. 4682
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged ≥5 years after 13-valent pneumococcal conjugate vaccine introduction—Alaska, 2008–2013
by Gounder, Prabhu P and Bruden, Dana and Rudolph, Karen and Zulz, Tammy and Hurlburt, Debby and Thompson, Gail and Bruce, Michael G and Hennessy, Thomas W
Vaccine, ISSN 0264-410X, 01/2018, Volume 36, Issue 5, pp. 691 - 697
The pneumococcal conjugate vaccine (PCV) was introduced in 2001. Widespread PCV use nearly eradicated pneumococcal colonization by vaccine serotypes. Since... 
Pneumococcal vaccines | Invasive pneumococcal disease | Alaska Native people | MEDICINE, RESEARCH & EXPERIMENTAL | PROTECTION | EFFICACY | INVASIVE DISEASE | IMMUNOLOGY | NASOPHARYNGEAL CARRIAGE | CHILDREN | IMPACT | STREPTOCOCCUS-PNEUMONIAE | DECADE | Immunization | Laboratories | Medical records | Vaccines | Epidemiology | Antiinfectives and antibacterials | Demographics | Serotypes | Villages | Children | Antimicrobial resistance | Colonization | Genotypes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011
by Bruce, Michael G and Zulz, Tammy and DeByle, Carolynn and Singleton, Ros and Hurlburt, Debby and Bruden, Dana and Rudolph, Karen and Hennessy, Thomas and Klejka, Joseph and Wenger, Jay D
Emerging Infectious Diseases, ISSN 1080-6040, 06/2013, Volume 19, Issue 6, pp. 932 - 937
Before introduction of Haemophilus influenzae type b (Hib) vaccines, rates of Hib disease in Alaska's indigenous people were among the highest in the world.... 
STRAINS | POPULATION | INFECTIOUS DISEASES | CARRIAGE | CANADA | VACCINE | RISK | IMMUNOLOGY | A DISEASE | EPIDEMIOLOGY | PCR | CHILDREN | Geography | History, 21st Century | History, 20th Century | Humans | Middle Aged | Child, Preschool | Haemophilus Infections - epidemiology | Haemophilus influenzae - genetics | Infant | Multilocus Sequence Typing | Incidence | Young Adult | Haemophilus Infections - history | Alaska - epidemiology | Disease Outbreaks | Public Health Surveillance | Adolescent | Adult | Child | Haemophilus influenzae - classification | Serotyping | Epidemics | Disease transmission | Distribution | Alaska | Research | Statistics | Hemophilus influenzae | Infection control | Index Medicus | H. influenzae | Hib | Hia | Alaska Native people | septic arthritis | bacteria | epiglottitis | United States | otitis media | invasive disease | meningitis | coccobacillus | Haemophilus influenzae | pneumonia | pericarditis | cellulitis | bacteremia | serotype | emerging pathogen
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections
by Brian J. McMahon and Thomas W. Hennessy and J. Michael Bensler and Dana L. Bruden and Alan J. Parkinson and Julie M. Morris and Alisa L. Reasonover and Debby A. Hurlburt and Michael G. Bruce and Frank Sacco and Jay C. Butler
Annals of Internal Medicine, ISSN 0003-4819, 09/2003, Volume 139, Issue 6, pp. 463 - I10
Background: The relationship between previous antimicrobial treatments and infection with drug-resistant Helicobacter pylori is unknown. Objectives: To... 
UNITED-STATES | CLARITHROMYCIN | POPULATION | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | TRIPLE THERAPIES | SUSCEPTIBILITY | ANTIBIOTIC-RESISTANCE | ERADICATION | METRONIDAZOLE RESISTANCE | HIGH PREVALENCE | Follow-Up Studies | Clarithromycin - adverse effects | Humans | Middle Aged | Drug Resistance, Bacterial | Helicobacter pylori - drug effects | Male | Treatment Outcome | Helicobacter Infections - drug therapy | Metronidazole - adverse effects | Adult | Female | Aged | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Cohort Studies | Helicobacter Infections - microbiology | Causes of | Drug resistance in microorganisms | Helicobacter infections | Drug therapy | Medical research | Microorganisms | Infections | Antibiotics | Drug resistance | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Using pneumococcal carriage data to monitor postvaccination changes in invasive disease
by Weinberger, Daniel M and Bruden, Dana T and Grant, Lindsay R and Lipsitch, Marc and O'Brien, Katherine L and Pelton, Stephen I and Sanders, Elisabeth A. M and Feikin, Daniel R
American Journal of Epidemiology, ISSN 0002-9262, 11/2013, Volume 178, Issue 9, pp. 1488 - 1495
Pneumococcal conjugate vaccines (PCVs) have been introduced worldwide. However, few developing countries have high-quality surveillance systems available for... 
Conjugate vaccine, pneumococcal | Vaccines | Surveillance | Pneumococcus | Vaccine effectiveness | Carriage | carriage | vaccines | conjugate vaccine | COLONIZATION | pneumococcal | CONJUGATE VACCINE USE | vaccine effectiveness | pneumococcus | IMPACT | TRANSMISSION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | STREPTOCOCCUS-PNEUMONIAE | DECADE | ALASKAN CHILDREN | surveillance | SEROTYPE REPLACEMENT | Carrier State - epidemiology | Pneumococcal Infections - epidemiology | Humans | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - administration & dosage | Models, Statistical | Nasopharynx - microbiology | Sentinel Surveillance | Incidence | Evaluation | Usage | Vaccination | Pneumococcal vaccine | Sentinel health events | Pneumococcal infections | Risk factors | Studies | Changes | Immunization | Index Medicus | Practice of Epidemiology | conjugate vaccine, pneumococcal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights